Action Medical Research: celebrating decades of discovery
The UK BioIndustry Association has named Action Medical Research as its charity of the year for 2019. With a focus...
Focus:
-
![Drug development: the researchers driving an open-science approach]()
Drug development: the researchers driving an open-science approach
-
![Gene genie: can CRISPR-Cas9 deliver on its promise to transform genome therapy?]()
Gene genie: can CRISPR-Cas9 deliver on its promise to transform genome therapy?
-
![Drugs from corn? Harvesting Mirexus’ phytoglycogen nano-particle]()
Drugs from corn? Harvesting Mirexus’ phytoglycogen nano-particle
-
![FDA expands Ibrance’s label to include male breast cancer patients]()
FDA expands Ibrance’s label to include male breast cancer patients
-
![Gilead submits sNDA to FDA to expand HIV label for Descovy]()
Gilead submits sNDA to FDA to expand HIV label for Descovy
-
![NICE recommends BMS’ Opdivo-Yervoy combination for RCC]()
NICE recommends BMS’ Opdivo-Yervoy combination for RCC
Expert commentary & analysis from GlobalData
Parkinson’s gene therapy development to restart in summer 2019
Minerva to explore therapy in treatment-naïve schizophrenia and more
ViiV adds another innovative treatment to its growing HIV arsenal
NDAs submitted to the FDA for the first oral GLP-1 receptor agonist
Most Read
Company releases
Erdmann Design’s Identity Establishing Brand Development Model SOPHI
SOPHI was designed using Erdmann Design's model for identity establishing brand development accompanying human-centred design.
Nymi to Host ‘Delivering Business Value from Biometric Security’ Webinar
Zenith Technologies Launches 24/7 Life Science Manufacturing IT Service
Zenith Technologies has launched and released a global 24/7 manufacturing IT support service specially designed to meet the support needs of the...
Case Study: Corporate Branding for Xorella
Case Study: Interactive Design for Stryker Group
Erdmann Design designed and implemented a user interface for Stryker for the company's screen-controlled navigation...
Company whitepapers
SOPHI: Identity Establishing Brand Development
Erdmann DesignThe Nymi™ Band
Nymi™Designed for the User
Erdmann DesignWater Purification Systems
DJA PharmaWhat Does Poor Quality Cost?
NSF International, Pharma BiotechPneumatic Conveying
HECHTDisclosure as a Service Case Study: Small Biotech Firm Manages Disclosure
TrialScopeCompany A-Z
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Projects
CPI Wet Granulation Manufacturing Facility, Durham, UK
In April 2019, Centre for Process Innovation (CPI) announced plans to develop a wet granulation manufacturing facility in Durham, UK.
Merck’s Biotech Manufacturing Facility Expansion, Aubonne, Switzerland
Regenxbio’s Research and Development Facility, Maryland
Cellectis’ Cellular Therapies Manufacturing Facility, Raleigh, North Carolina
Amicus Therapeutics’ Global Research and Gene Therapy Centre, Philadelphia
Clinical Trials
ViiV announces long-term positive results for Juluca combination
London-based ViiV Healthcare has announced three-year results from its Sword-1 and Sword-2 trials.
NIH initiates first clinical trial of universal influenza vaccine
Sangamo announces promising early results for haemophilia A gene therapy
FDA grants AstraZeneca-Merck’s selumetinib breakthrough therapy designation
Penn presents positive results for targeted leukaemia drug
Drug Development
Boehringer partners PureTech to develop immuno-oncology candidates
Boehringer Ingelheim has formed an alliance with US-based PureTech Health to develop new drug candidates for a variety of targets using lymphatic targeting technology.
Pulmatrix and Cipla collaborate to develop asthma drug
Gilead and insitro team up to develop treatment for NASH
Enesi Pharma partners with US BARDA on new flu vaccines
Regeneron and Alnylam partner on eye and CNS disease therapies
Market Data
Bristol-Myers $74bn Celgene takeover gets shareholders approvals
Bristol-Myers Squibb has secured shareholders’ approval for its $74bn acquisition of biotechnology company Celgene. More than 75% of the shareholders voted in favour of the...
Sanofi to slash costs of certain insulin products in US
Sandoz to commercialise Shionogi’s Rizmoic in European markets
Jazz, Alexion and Lundbeck to pay $122m to settle kickback probe
AgomAb secures funds to support regeneration therapies
Technology
Study shows CRISPR could help treat lung disease in utero
A proof-of-concept study by Penn Medicine and Children’s Hospital of Philadelphia (CHOP) in the US has offered hope for the treatment of lung diseases before...
Pfizer to use Concerto HealthAI technology for cancer treatments
Blue Brain Project clarifies neurons’ structure and role in disease
NASA calls for new vaccinations to combat virus reactivation during spaceflight
Microsoft unveils new platform to boost therapeutics production
Go Top